Acute Porphyria Drugs

A02BB01 - Misoprostol

Propably not porphyrinogenic
PNP

Rationale
Prostaglandin. Probably only insignificant hepatic exposure.
Chemical description
Tablets; 0.2-0.8 mg/d. Synthetic prostaglandin, which is inhibitor of ventricular secretion. Mucosaprotective effect against ASA induced ventricular lesions. Metabolized in several organs by beta-omega oxidation. Misoprostol and misoprostolic acid is excrered by the kidneys and faeces as various metabolites. South African list: use with extreme caution only. French list: authorized
IPNet drug reports
Uneventful use reported in 2 patients with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes A02B / A02BB or go back.
References
Tradenames

Cytotec Cytotec Cytotec Cytotec Cytotec Cytotec · Misoprostol Cytotec Cytotec · Misoprostol Cytotec Misoprostol Cytotec Cytotec Cytotec Cytotec Cyprostol · Cytotec Misprostol
In cooperation with IpNet
© NAPOS 2025
An unhandled error has occurred. Reload 🗙